Worth reading
55In focus
Scored from 5 of 6 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
84
Millions of yenWording
Conditional
How definitive the wording is.Results for this period
Interim period (second quarter)1 January 2026–30 June 2026ConsolidatedJapanese GAAPNet Sales4,413Millions of yenYear on year -0.1%Progress 51.0%
Operating profit358Millions of yenYear on year +31.0%Progress 56.8%
Ordinary income307Millions of yenYear on year +3.4%Progress 56.6%
Net income attributable to owners of the parent201Millions of yenYear on year +15.6%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥24.85
Financial position at period-end
Total assets10,234Millions of yen
of which net assets 4,143 Millions of yenEquity ratio 40.5%vs. prior year-end +2.7pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Segment revenue
Precision Injection Molds and Molding Systems business1,452,91132.7%
Precision Molded Products and Other Businesses2,992,88067.3%
Segment profit
Precision Injection Molds and Molding Systems business81,04122.7%
Precision Molded Products and Other Businesses276,43377.3%
Outlook and shareholder returns
Full-year earnings forecast
Net Sales8,657 Millions of yen (YoY -2.0%)
Operating profit630 Millions of yen (YoY +27.5%)
Ordinary income542 Millions of yen (YoY +23.4%)
Profit attributable to owners of the parent367 Millions of yen (YoY +26.6%)
Revision to Earnings ForecastNet Sales Not disclosed → 8,657 Millions of yen / Operating profit Not disclosed → 630 Millions of yen / Ordinary income Not disclosed → 542 Millions of yen / Profit attributable to owners of the parent Not disclosed → 367 Millions of yen
Annual Dividend Forecast¥7 → ¥10
Factors Behind Changes in Business Performance
The Injection Molding Precision Molds and Molding Systems Business reported lower sales and lower profit due to a decrease in sales of precision molds for medical equipment and a challenging order environment. The Precision Molded Products and Other Business reported higher sales at subsidiaries in Indonesia, Thailand and Japan, and higher profit due to the effects of passing through higher prices and increased sales.
Disclosure regarding the going concern assumption
No applicable matters
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationAdded: 0 companies; excluded: 0 companies
Impairment lossNone for the interim consolidated accounting period
Breakdown of extraordinary income (loss)Extraordinary income Item Gain on sale of non-current assets / Amount ¥8,756 thousand / Extraordinary loss Item Loss on sale of fixed assets / Amount ¥10,339 thousand, Item Loss on Disposal of Fixed Assets / Amount ¥5,932 thousand
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingNone (対象者：Not disclosed)
Issued Shares at Period-End9,054,000
Treasury Shares at Period-End959,340
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–30 June 2026 |
| Net Sales | 4,413 Millions of yen (YoY -0.1%) |
| Operating profit | 358 Millions of yen (YoY +31.0%) |
| Ordinary income | 307 Millions of yen (YoY +3.4%) |
| Profit attributable to owners of the parent | 201 Millions of yen (YoY +15.6%) |
| Net income per share | ¥24.85 |
| Equity ratio | End of the current fiscal period 40.5 / End of previous period 37.8 |
| Total assets | 10,234 Millions of yen |
| Net assets | 4,143 Millions of yen |
| Full-year earnings forecast | Net Sales 8,657 Millions of yen (YoY -2.0%) / Operating profit 630 Millions of yen (YoY +27.5%) / Ordinary income 542 Millions of yen (YoY +23.4%) / Profit attributable to owners of the parent 367 Millions of yen (YoY +26.6%) |
| Revision to Earnings Forecast | Net Sales Not disclosed → 8,657 Millions of yen / Operating profit Not disclosed → 630 Millions of yen / Ordinary income Not disclosed → 542 Millions of yen / Profit attributable to owners of the parent Not disclosed → 367 Millions of yen |
| Annual Dividend Forecast | ¥7 → ¥10 |
| Segment revenue | Segment Precision Injection Molds and Molding Systems business / Net Sales ¥1,452,911 thousand (YoY -13.4%), Segment Precision Molded Products and Other Businesses / Net Sales ¥2,992,880 thousand (YoY +7.2%) |
| Segment profit | Segment Precision Injection Molds and Molding Systems business / Segment profit ¥81,041 thousand (YoY -35.1%), Segment Precision Molded Products and Other Businesses / Segment profit ¥276,433 thousand (YoY +85.0%) |
| Impairment loss | None for the interim consolidated accounting period |
| Breakdown of extraordinary income (loss) | Extraordinary income Item Gain on sale of non-current assets / Amount ¥8,756 thousand / Extraordinary loss Item Loss on sale of fixed assets / Amount ¥10,339 thousand, Item Loss on Disposal of Fixed Assets / Amount ¥5,932 thousand |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | Added: 0 companies; excluded: 0 companies |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | None (対象者：Not disclosed) |
| Issued Shares at Period-End | 9,054,000 |
| Treasury Shares at Period-End | 959,340 |
| Factors Behind Changes in Business Performance | The Injection Molding Precision Molds and Molding Systems Business reported lower sales and lower profit due to a decrease in sales of precision molds for medical equipment and a challenging order environment. The Precision Molded Products and Other Business reported higher sales at subsidiaries in Indonesia, Thailand and Japan, and higher profit due to the effects of passing through higher prices and increased sales. |
Items this document does not state (11)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodPayout ratioShareholder Return PolicyRegional salesOrders received and order backlogDepreciation and amortizationMaterial subsequent events
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Operating profit increased because gross profit in the Precision Molded Products and Other Business increased, despite higher selling, general and administrative expenses, including salaries and training expenses. The full-year earnings forecast was revised based on recent business performance trends.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.